OBJECTIVES: Sutureless and rapid-deployment valves were recently introduced into clinical practice. The Edwards INTUITY valve system is a combination of the Edwards Magna pericardial valve and a subvalvular stent-frame to enable rapid deployment. We performed a parallel cohort study for comparison of the two valve types. METHODS: All patients receiving either an Edwards Magna Ease valve or an Edwards INTUITY valve system due to aortic stenosis from May 2010 until July 2014 were included. Patients undergoing bypass surgery, an additional valve procedure, atrial ablation surgery or replacement of the ascending aorta were excluded. Preoperative characteristics, operative specifications, survival, valve-related adverse events and transvalvulvar gradients were compared. RESULTS: One hundred sixteen patients underwent rapid-deployment aortic valve replacement [mean age 75 years (SD: 8); 62% female] and 132 patients underwent conventional aortic valve replacement [70 years (SD: 9); 31% female; P < 0.001]. Conventional valve patients were taller and heavier. The mean EuroSCORE II was 3.1% (SD: 2.7) and 4.4% (SD: 6.0) for rapid-deployment and conventional valve patients, respectively (P = 0.085). The mean implanted valve size was higher in the conventional group [23.2 mm (SD: 2.0) vs 22.5 mm (SD: 2.2); P = 0.007], but postoperative transvalvular mean gradients were comparable [15 mmHg (SD: 6) vs 14 mmHg (SD: 5); P = 0.457]. A subgroup analysis of the most common valve sizes (21 and 23 mm; implanted in 63% of patients) revealed significantly reduced mean postoperative transvalvular gradients in the rapid-deployment group [14 mmHg (SD: 4) vs 16 mmHg (SD: 5); P = 0.025]. A significantly higher percentage received minimally invasive procedures in the rapid-deployment group (59 vs 39%; P < 0.001). The 1- and 3-year survival rate was 96 and 90% in the rapid-deployment group and 95 and 89% in the conventional group (P = 0.521), respectively. Valve-related pacemaker implantations were more common in the rapid-deployment group (9 vs 2%; P = 0.014) and postoperative stroke was more common in the conventional group (1.6 vs 0% per patient year; P = 0.044). CONCLUSIONS: We conclude that this rapid-deployment valve probably facilitates minimally invasive surgery. Furthermore, a subgroup analysis showed reduced transvalvular gradients in smaller valve sizes compared with the conventionally implanted valve of the same type. The favourable haemodynamic profile and the potentially different spectrum of valve-related adverse events should be addressed in further clinical trials.
OBJECTIVES: Sutureless and rapid-deployment valves were recently introduced into clinical practice. The Edwards INTUITY valve system is a combination of the Edwards Magna pericardial valve and a subvalvular stent-frame to enable rapid deployment. We performed a parallel cohort study for comparison of the two valve types. METHODS: All patients receiving either an Edwards Magna Ease valve or an Edwards INTUITY valve system due to aortic stenosis from May 2010 until July 2014 were included. Patients undergoing bypass surgery, an additional valve procedure, atrial ablation surgery or replacement of the ascending aorta were excluded. Preoperative characteristics, operative specifications, survival, valve-related adverse events and transvalvulvar gradients were compared. RESULTS: One hundred sixteen patients underwent rapid-deployment aortic valve replacement [mean age 75 years (SD: 8); 62% female] and 132 patients underwent conventional aortic valve replacement [70 years (SD: 9); 31% female; P < 0.001]. Conventional valve patients were taller and heavier. The mean EuroSCORE II was 3.1% (SD: 2.7) and 4.4% (SD: 6.0) for rapid-deployment and conventional valve patients, respectively (P = 0.085). The mean implanted valve size was higher in the conventional group [23.2 mm (SD: 2.0) vs 22.5 mm (SD: 2.2); P = 0.007], but postoperative transvalvular mean gradients were comparable [15 mmHg (SD: 6) vs 14 mmHg (SD: 5); P = 0.457]. A subgroup analysis of the most common valve sizes (21 and 23 mm; implanted in 63% of patients) revealed significantly reduced mean postoperative transvalvular gradients in the rapid-deployment group [14 mmHg (SD: 4) vs 16 mmHg (SD: 5); P = 0.025]. A significantly higher percentage received minimally invasive procedures in the rapid-deployment group (59 vs 39%; P < 0.001). The 1- and 3-year survival rate was 96 and 90% in the rapid-deployment group and 95 and 89% in the conventional group (P = 0.521), respectively. Valve-related pacemaker implantations were more common in the rapid-deployment group (9 vs 2%; P = 0.014) and postoperative stroke was more common in the conventional group (1.6 vs 0% per patient year; P = 0.044). CONCLUSIONS: We conclude that this rapid-deployment valve probably facilitates minimally invasive surgery. Furthermore, a subgroup analysis showed reduced transvalvular gradients in smaller valve sizes compared with the conventionally implanted valve of the same type. The favourable haemodynamic profile and the potentially different spectrum of valve-related adverse events should be addressed in further clinical trials.
Authors: Cary W Akins; D Craig Miller; Marko I Turina; Nicholas T Kouchoukos; Eugene H Blackstone; Gary L Grunkemeier; Johanna J M Takkenberg; Tirone E David; Eric G Butchart; David H Adams; David M Shahian; Siegfried Hagl; John E Mayer; Bruce W Lytle Journal: Eur J Cardiothorac Surg Date: 2008-03-04 Impact factor: 4.191
Authors: Alfred A Kocher; Günther Laufer; Axel Haverich; Malakh Shrestha; Thomas Walther; Martin Misfeld; Joerg Kempfert; Linda Gillam; Christoph Schmitz; Thorsten C Wahlers; Jens Wippermann; Friedrich W Mohr; Matthias Roth; Adalbert Skwara; Parwis Rahmanian; Dominik Wiedemann; Michael A Borger Journal: J Thorac Cardiovasc Surg Date: 2012-10-08 Impact factor: 5.209
Authors: Michael A Borger; Vadim Moustafine; Lenard Conradi; Christoph Knosalla; Markus Richter; Denis R Merk; Torsten Doenst; Robert Hammerschmidt; Hendrik Treede; Pascal Dohmen; Justus T Strauch Journal: Ann Thorac Surg Date: 2014-11-20 Impact factor: 4.330
Authors: Jessica Forcillo; Michel Pellerin; Louis P Perrault; Raymond Cartier; Denis Bouchard; Philippe Demers; Michel Carrier Journal: Ann Thorac Surg Date: 2013-05-14 Impact factor: 4.330
Authors: Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala Journal: Eur J Cardiothorac Surg Date: 2012-08-25 Impact factor: 4.191
Authors: Axel Haverich; Thorsten C Wahlers; Michael A Borger; Malakh Shrestha; Alfred A Kocher; Thomas Walther; Matthias Roth; Martin Misfeld; Friedrich W Mohr; Joerg Kempfert; Pascal M Dohmen; Christoph Schmitz; Parwis Rahmanian; Dominik Wiedemann; Francis G Duhay; Günther Laufer Journal: J Thorac Cardiovasc Surg Date: 2014-08-01 Impact factor: 5.209
Authors: Martin Andreas; Stephanie Wallner; Kurt Ruetzler; Dominik Wiedemann; Marek Ehrlich; Georg Heinze; Thomas Binder; Anton Moritz; Michael J Hiesmayr; Alfred Kocher; Guenther Laufer Journal: Eur J Cardiothorac Surg Date: 2014-12-18 Impact factor: 4.191
Authors: Vahid Sadri; Charles H Bloodworth; Immanuel David Madukauwa-David; Prem A Midha; Vrishank Raghav; Ajit P Yoganathan Journal: Gen Thorac Cardiovasc Surg Date: 2019-06-27
Authors: Paolo Berretta; Mariano Cefarelli; Walter Vessella; Michele D Pierri; Roberto Carozza; Giulia Abramucci; Christopher Munch; Hossein M Zahedi; Marco Di Eusanio Journal: J Vis Surg Date: 2018-05-08
Authors: Iuliana Coti; Thomas Haberl; Sabine Scherzer; Paul Werner; Shiva Shabanian; Alfred Kocher; Guenther Laufer; Martin Andreas Journal: Ann Cardiothorac Surg Date: 2020-07
Authors: Paolo Berretta; Luca Montecchiani; Fabio Vagnarelli; Mariano Cefarelli; Jacopo Alfonsi; Carlo Zingaro; Filippo Capestro; Michele D Pierri; Alessandro D'alfonso; Marco Di Eusanio Journal: Ann Cardiothorac Surg Date: 2020-09
Authors: Claudio Capelli; Chiara Corsini; Dario Biscarini; Francesco Ruffini; Francesco Migliavacca; Alfred Kocher; Guenther Laufer; Andrew M Taylor; Silvia Schievano; Martin Andreas; Gaetano Burriesci; Claus Rath Journal: Cardiovasc Eng Technol Date: 2016-11-21 Impact factor: 2.495
Authors: José M Arribas-Leal; José Miguel Rivera-Caravaca; Ramón Aranda-Domene; José A Moreno-Moreno; Dolores Espinosa-Garcia; Antonio Jimenez-Aceituna; Joaquín Perez-Andreu; Rubén Taboada-Martin; Daniel R Saura-Espin; Sergio J Canovas-Lopez Journal: Interact Cardiovasc Thorac Surg Date: 2021-10-29